📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates. (2022)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/22221751.2022.2099304

PubMed Identifier: 35792049

Publication URI: http://europepmc.org/abstract/MED/35792049

Type: Journal Article/Review

Volume: 11

Parent Publication: Emerging microbes & infections

Issue: 1

ISSN: 2222-1751